CXCR4 and ovarian neoplasm: Here we showed that locoregional delivery of the CXCR4-A-armed virus is more efficacious in inhibiting orthotopic growth of ovarian tumors than i.v. injection of the unarmed counterpart, possibly because of a higher accumulation of the antagonist in the tumor than in systemic tissues.